Allspring Global Investments Holdings, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 2,287 shares of RARE stock, worth $94,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,287
Previous 3,331
31.34%
Holding current value
$94,910
Previous $136,000
6.62%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.6MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$413 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$233 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$212 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$173 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$127 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.91B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...